vs

Side-by-side financial comparison of indie Semiconductor, Inc. (INDI) and PETMED EXPRESS INC (PETS). Click either name above to swap in a different company.

indie Semiconductor, Inc. is the larger business by last-quarter revenue ($58.0M vs $40.7M, roughly 1.4× PETMED EXPRESS INC). PETMED EXPRESS INC runs the higher net margin — -26.0% vs -53.8%, a 27.9% gap on every dollar of revenue. On growth, indie Semiconductor, Inc. posted the faster year-over-year revenue change (-0.0% vs -23.3%). PETMED EXPRESS INC produced more free cash flow last quarter ($-9.2M vs $-16.1M). Over the past eight quarters, indie Semiconductor, Inc.'s revenue compounded faster (5.3% CAGR vs -20.9%).

indie Semiconductor is a fabless semiconductor manufacturer focused on designing high-performance mixed-signal and embedded system-on-chip solutions for the automotive industry. Its products support advanced driver assistance systems, in-vehicle infotainment, connected car, and electric vehicle applications, serving global auto OEMs and tier 1 suppliers across major global markets.

PetMed Express, Inc., also known as PetMeds, is an online pet pharmacy based in the United States. It is publicly traded and sells prescription and non-prescription pet medication.

INDI vs PETS — Head-to-Head

Bigger by revenue
INDI
INDI
1.4× larger
INDI
$58.0M
$40.7M
PETS
Growing faster (revenue YoY)
INDI
INDI
+23.3% gap
INDI
-0.0%
-23.3%
PETS
Higher net margin
PETS
PETS
27.9% more per $
PETS
-26.0%
-53.8%
INDI
More free cash flow
PETS
PETS
$6.9M more FCF
PETS
$-9.2M
$-16.1M
INDI
Faster 2-yr revenue CAGR
INDI
INDI
Annualised
INDI
5.3%
-20.9%
PETS

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
INDI
INDI
PETS
PETS
Revenue
$58.0M
$40.7M
Net Profit
$-31.2M
$-10.6M
Gross Margin
37.3%
23.3%
Operating Margin
-58.5%
-25.7%
Net Margin
-53.8%
-26.0%
Revenue YoY
-0.0%
-23.3%
Net Profit YoY
9.1%
-1392.6%
EPS (diluted)
$-0.16
$-0.50

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
INDI
INDI
PETS
PETS
Q4 25
$58.0M
$40.7M
Q3 25
$53.7M
$44.4M
Q2 25
$51.6M
$51.2M
Q1 25
$54.1M
$50.8M
Q4 24
$58.0M
$52.0M
Q3 24
$54.0M
$58.0M
Q2 24
$52.4M
$66.2M
Q1 24
$52.4M
$65.1M
Net Profit
INDI
INDI
PETS
PETS
Q4 25
$-31.2M
$-10.6M
Q3 25
$-38.3M
$-8.5M
Q2 25
$-39.0M
$-34.2M
Q1 25
$-34.5M
$-11.6M
Q4 24
$-34.4M
$-707.0K
Q3 24
$-49.7M
$2.3M
Q2 24
$-19.2M
$3.8M
Q1 24
$-31.2M
$-5.0M
Gross Margin
INDI
INDI
PETS
PETS
Q4 25
37.3%
23.3%
Q3 25
40.1%
28.0%
Q2 25
40.6%
28.1%
Q1 25
41.7%
29.9%
Q4 24
42.6%
31.0%
Q3 24
39.3%
32.3%
Q2 24
42.2%
28.8%
Q1 24
42.5%
29.3%
Operating Margin
INDI
INDI
PETS
PETS
Q4 25
-58.5%
-25.7%
Q3 25
-71.4%
-18.9%
Q2 25
-83.3%
-66.7%
Q1 25
-72.0%
-11.9%
Q4 24
-58.4%
-0.9%
Q3 24
-92.5%
1.0%
Q2 24
-70.0%
6.6%
Q1 24
-94.8%
-5.9%
Net Margin
INDI
INDI
PETS
PETS
Q4 25
-53.8%
-26.0%
Q3 25
-71.3%
-19.2%
Q2 25
-75.6%
-66.7%
Q1 25
-63.9%
-22.9%
Q4 24
-59.2%
-1.4%
Q3 24
-92.1%
4.0%
Q2 24
-36.6%
5.7%
Q1 24
-59.6%
-7.7%
EPS (diluted)
INDI
INDI
PETS
PETS
Q4 25
$-0.16
$-0.50
Q3 25
$-0.19
$-0.41
Q2 25
$-0.20
$-1.65
Q1 25
$-0.18
$-0.56
Q4 24
$-0.18
$-0.03
Q3 24
$-0.28
$0.11
Q2 24
$-0.11
$0.18
Q1 24
$-0.19
$-0.24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
INDI
INDI
PETS
PETS
Cash + ST InvestmentsLiquidity on hand
$145.5M
$26.9M
Total DebtLower is stronger
$353.4M
Stockholders' EquityBook value
$358.0M
$32.8M
Total Assets
$840.8M
$88.0M
Debt / EquityLower = less leverage
0.99×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
INDI
INDI
PETS
PETS
Q4 25
$145.5M
$26.9M
Q3 25
$160.9M
$36.1M
Q2 25
$192.6M
$41.1M
Q1 25
$236.6M
$54.7M
Q4 24
$274.2M
$50.1M
Q3 24
$96.9M
$52.0M
Q2 24
$112.3M
$46.0M
Q1 24
$138.2M
$55.3M
Total Debt
INDI
INDI
PETS
PETS
Q4 25
$353.4M
Q3 25
$353.5M
Q2 25
$352.5M
Q1 25
$379.0M
Q4 24
$381.3M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
INDI
INDI
PETS
PETS
Q4 25
$358.0M
$32.8M
Q3 25
$369.2M
$43.1M
Q2 25
$390.4M
$51.5M
Q1 25
$405.6M
$85.1M
Q4 24
$417.9M
$96.2M
Q3 24
$458.6M
$96.4M
Q2 24
$470.7M
$93.5M
Q1 24
$432.9M
$96.7M
Total Assets
INDI
INDI
PETS
PETS
Q4 25
$840.8M
$88.0M
Q3 25
$855.1M
$100.3M
Q2 25
$867.6M
$109.8M
Q1 25
$909.0M
$148.7M
Q4 24
$941.4M
$144.8M
Q3 24
$797.5M
$146.0M
Q2 24
$797.3M
$152.7M
Q1 24
$803.6M
$169.9M
Debt / Equity
INDI
INDI
PETS
PETS
Q4 25
0.99×
Q3 25
0.96×
Q2 25
0.90×
Q1 25
0.93×
Q4 24
0.91×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
INDI
INDI
PETS
PETS
Operating Cash FlowLast quarter
$-14.4M
$-9.2M
Free Cash FlowOCF − Capex
$-16.1M
$-9.2M
FCF MarginFCF / Revenue
-27.8%
-22.7%
Capex IntensityCapex / Revenue
3.0%
0.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-71.4M
$-23.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
INDI
INDI
PETS
PETS
Q4 25
$-14.4M
$-9.2M
Q3 25
$-6.2M
$-2.2M
Q2 25
$-7.6M
$-12.3M
Q1 25
$-29.0M
$7.0M
Q4 24
$-6.7M
$-1.2M
Q3 24
$-22.8M
$7.4M
Q2 24
$-19.7M
$-8.5M
Q1 24
$-9.3M
$7.1M
Free Cash Flow
INDI
INDI
PETS
PETS
Q4 25
$-16.1M
$-9.2M
Q3 25
$-10.3M
$-4.8M
Q2 25
$-13.6M
$-13.6M
Q1 25
$-31.4M
$4.6M
Q4 24
$-8.6M
$-1.9M
Q3 24
$-29.3M
$6.1M
Q2 24
$-23.4M
$-9.2M
Q1 24
$-11.7M
$5.9M
FCF Margin
INDI
INDI
PETS
PETS
Q4 25
-27.8%
-22.7%
Q3 25
-19.2%
-10.8%
Q2 25
-26.4%
-26.5%
Q1 25
-58.0%
9.1%
Q4 24
-14.8%
-3.7%
Q3 24
-54.3%
10.6%
Q2 24
-44.7%
-13.9%
Q1 24
-22.3%
9.0%
Capex Intensity
INDI
INDI
PETS
PETS
Q4 25
3.0%
0.1%
Q3 25
7.8%
5.9%
Q2 25
11.6%
2.5%
Q1 25
4.4%
4.7%
Q4 24
3.2%
1.5%
Q3 24
12.1%
2.2%
Q2 24
7.0%
1.0%
Q1 24
4.4%
1.9%
Cash Conversion
INDI
INDI
PETS
PETS
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
3.18×
Q2 24
-2.27×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

INDI
INDI

Products$55.7M96%
Services$2.3M4%

PETS
PETS

Reorder$34.0M84%
New Order$5.0M12%
Membership Fees$1.6M4%

Related Comparisons